|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$78,482.18 |
2.35% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$75,446.10 |
2.26% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$73,248.78 |
2.20% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$72,959.61 |
2.19% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$72,851.99 |
2.18% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$72,749.14 |
2.18% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$72,864.31 |
2.18% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$71,737.05 |
2.15% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$71,536.08 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$71,487.69 |
2.14% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$71,490.24 |
2.14% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$71,514.45 |
2.14% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$71,223.25 |
2.14% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,035.48 |
2.13% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,834.90 |
2.12% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,234.80 |
2.11% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$70,502.48 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$69,619.64 |
2.09% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$69,689.08 |
2.09% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$68,963.16 |
2.07% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$69,020.68 |
2.07% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,942.29 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
298 |
$68,942.30 |
2.07% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,530.49 |
2.05% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$68,200.06 |
2.05% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$67,907.84 |
2.04% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$67,844.20 |
2.03% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,738.98 |
2.03% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,605.30 |
2.03% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$66,962.23 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$66,962.01 |
2.01% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$66,876.30 |
2.01% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$67,007.50 |
2.01% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,194.32 |
2.01% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$66,553.25 |
2.00% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$66,583.48 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$65,797.50 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$65,609.25 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$65,119.50 |
1.95% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$63,915.80 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,004.00 |
1.92% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$63,057.20 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$63,128.24 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$61,990.81 |
1.86% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$61,689.28 |
1.85% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$61,494.62 |
1.84% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,119.80 |
1.65% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$53,314.99 |
1.60% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,536.62 |
1.34% |
| US Dollar |
$USD |
|
24,483 |
$24,482.67 |
0.73% |
| Japanese Yen |
$JPY |
|
42,336 |
$266.73 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|